Philogen Stock Quote PHIL - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

18.50

Bid

18.05

Ask

18.90

Volume

1,924

18.30 Day's Range 18.60

16.50 52 Week Range 21.90

Market Cap

747.356M

Previous Close

18.55

Open

18.60

Last Trade

18.5

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

5,543

Shares Outstanding

40,397,605

Dividend Yield

PE Ratio

0.00

Earnings Per Share (EPS)

Revenue

25.12M

Net Profit

-6.16M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.philogen.com

Headquarters

Siena, Siena, Ita

Founded

Philogen Spa is listed in the Pharmaceutical Preparations sector of the Italian Stock Exchange with ticker PHIL. The last closing price for Philogen was 18.55 €. Over the last year, Philogen shares have traded in a share price range of 16.50 € to 21.90 €.

Philogen currently has 40,397,605 shares outstanding. The market capitalization of Philogen is 749.38 € million.

FeaturedNorthstrive Biosciences Inc. Schedules Pre-IND Meeting with FDA for EL-22, an Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1

Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue Sarcoma

Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients...

Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities

Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by...

Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors

Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for...

Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma

Intratumoral Nidlegy™ followed by surgery significantly improved the Recurrence-Free Survival compared to...

Philogen Announces Clinical Trial Collaboration with MSD

Philogen Announces Clinical Trial Collaboration with MSD The Phase II clinical trial investigates Philogen's immunocytokines (i) L19IL2 (ii...

Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand

Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in...

Philogen Publishes New Data on a Fibromun-based treatment combination in Science Translational Medicine in collaboration with the University Hospital Zürich

Philogen Publishes New Data on a Fibromun-based treatment combination in Science Translational Medicine in collaboration with the University...

Philogen Announces Publication of a New Study in Collaboration with Google focused on Machine Learning models applied to DNA-Encoded Chemical Library Technology

Philogen Announces Publication of a New Study in Collaboration with Google focused on Machine Learning models applied to DNA-Encoded Chemical...

Philogen Provides Corporate Update

Philogen Provides Corporate Update Philogen Provides Corporate Update Nidlegy™ and Fibromun pivotal clinical trials on track Fibromun shows...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.15	-0.804289544236	18.65	19	18.05	4567	18.6224307	DE
4	0.3	1.64835164835	18.2	19	17.4	4980	18.40535942	DE
12	-0.25	-1.33333333333	18.75	19.75	16.5	5543	18.24985083	DE
26	-2.3	-11.0576923077	20.8	21.3	16.5	7071	19.29315399	DE
52	0.7	3.93258426966	17.8	21.9	16.5	8066	19.30041088	DE
156	4.98	36.8343195266	13.52	21.9	13	8383	17.11007407	DE
260	1.5	8.82352941176	17	21.9	12.6	11828	16.06668056	DE

PHIL - Frequently Asked Questions (FAQ)

What is the current Philogen share price?

The current share price of Philogen is 18.50 €

How many Philogen shares are in issue?

Philogen has 40,397,605 shares in issue

What is the market cap of Philogen?

The market capitalisation of Philogen is EUR 749.38M

What is the 1 year trading range for Philogen share price?

Philogen has traded in the range of 16.50 € to 21.90 € during the past year

What is the reporting currency for Philogen?

Philogen reports financial results in EUR

What is the latest annual turnover for Philogen?

The latest annual turnover of Philogen is EUR 25.12M

What is the latest annual profit for Philogen?

The latest annual profit of Philogen is EUR -6.16M

What is the registered address of Philogen?

The registered address for Philogen is PIAZZA LA LIZZA, 7, SIENA, SIENA, 53100

What is the Philogen website address?

The website address for Philogen is www.philogen.com

Which industry sector does Philogen operate in?

Philogen operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WHIK26Haiki Spa	0.098 € (29.80%)	73.06k
WTWL26TraWell Co SpA	0.33 € (24.06%)	10
CGFCogefeed SpA	0.70 € (16.67%)	8.5k
MPTImpianti SpA	0.69 € (13.11%)	231k
1CECCeconomy AG	3.512 € (11.07%)	6k
WS3D25Solid World Group spa	0.095 € (-26.92%)	10.9k
1LITELumentum Holdings Inc	53.38 € (-26.09%)	100
GTGT Talent Group SpA	0.20 € (-16.67%)	10.5k
1HU3Huntington Bancshs Inc	14.016 € (-15.89%)	3.7k
1RDDTReddit Inc	105.92 € (-15.20%)	240
TITTelecom Italia SpA	0.2743 € (-0.29%)	171.32M
ISPIntesa Sanpaolo Spa	4.796 € (-2.01%)	89.25M
SPMSaipem Spa	1.973 € (-3.05%)	44.66M
ENELEnel Spa	6.946 € (2.33%)	39.78M
BMPSBanca Monte Dei Paschi Di Siena Spa	6.87 € (-4.77%)	31.04M